Navigation Links
Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
Date:4/29/2008

an earlier stage of cell line development and product characterisation.

IPLEX(TM)

IPLEX(TM) is a complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its predominant binding protein IGFBP-3 (rhIGFBP-3). The drug, approved in the United States in December 2005 for the treatment of children with growth failure due to severe primary IGF-I deficiency, is currently being investigated in Myotonic Muscular Dystrophy (MMD) and Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's disease.

A Phase 2 trial of IPLEX(TM) in MMD is on-going and a substantial portion of the external costs associated with the study are expected to be covered by an approximately $2.1 million grant awarded to Insmed by the Muscular Dystrophy Association in late 2007.

MMD Phase 2 trial at-a-glance:

-- All sites have been initiated, received Investigational Review Board

approvals and are actively recruiting trial participants.

-- The trial is currently more than 50 percent enrolled.

-- The trial is on target to complete enrollment by mid-year 2008

-- Interim data analysis scheduled for fourth quarter 2008.

IPLEX(TM) is also in use as part of an Expanded Access Program (EAP) in partnership with the Italian Ministry of Health for the treatment of ALS. Since early 2007, the EAP has grown to include 20 physicians, and approximately 90 subjects have been enrolled into the program to date with additional subjects being enrolled as the program progresses. IPLEX(TM) continues to be safe and well tolerated in the subject population. During the first quarter of 2008, the EAP generated $2.3 million in cost recovery revenue for Insmed, compared to $0.7 million during the same period last year, and $2.0 million in the fourth quarter of 2007.

"We are pleased with the development progress and results to date of IPLEX(TM) in both MMD and ALS, especially considering the level of investment these therapeutic programs cur
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
2. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
3. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
4. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
5. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
6. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
7. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
8. Raptor Pharmaceuticals Provides Update of Product Programs
9. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
10. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
11. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... Valeant Pharmaceuticals International, Inc. (NYSE: VRX and ... prospectus supplement to its effective shelf registration statement on Form ... regulatory authorities in each of the provinces of ... its common shares to raise gross proceeds of approximately $1.75 ... to the underwriters of the Offering an option, exercisable for ...
(Date:6/17/2013)... June 17, 2013 /PRNewswire-iReach/ -- Weiler Labeling Systems, ... X-4S pressure sensitive labeling head. The X-4S is ... performance requirements that serialization demands. ... uniquely qualified to work with pharmaceutical and medical ... and track and trace implementation strategies. Designed for ...
(Date:6/17/2013)... Franciscan St. Francis Health Cancer Center today (June ... to use a new drug to treat men ... Xofigo ®, a radiopharmaceutical used in patients with late-stage, metastatic ... approved for use by the U.S. Food and Drug Administration. ... may become castration-resistant, which has become resistant to medical or ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4Weiler Labeling Introduces Serialization-Capable X-4S Labeling Head 2New drug proving effective in attacking advanced prostate cancer 2
... The U.S. Food and Drug Administration has completed ... help speed safe and effective drugs and lower-cost generic ... Margaret A. Hamburg, M.D. said today. The recommendations were ... Secretary Kathleen Sebelius. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ...
... (NYSE: IBM ) scientists have developed a ... can aid researchers and pathologists to investigate critical ... diagnostics. Flickr Photos: http://www.flickr.com/photos/ibm_research_zurich/sets/72157628678347543 ... used in pathology to detect disease markers in ...
Cached Medicine Technology:FDA Completes Work on Three Drug User Fee Programs 2FDA Completes Work on Three Drug User Fee Programs 3FDA Completes Work on Three Drug User Fee Programs 4MADE IN IBM LABS: New Silicon Probe Assists in Disease Diagnostics and Drug Discovery 2MADE IN IBM LABS: New Silicon Probe Assists in Disease Diagnostics and Drug Discovery 3MADE IN IBM LABS: New Silicon Probe Assists in Disease Diagnostics and Drug Discovery 4
(Date:6/17/2013)... Drug Administration (FDA) imposes new graphic warning labels ... Amendment challenge if they depict health consequences and ... says a Georgetown University Medical Center public health ... labelswhich combine images with health warningsare a widely ... countries, but the tobacco industry argues they are ...
(Date:6/17/2013)... 17, 2013 Daimer Industries, Inc.®, a ... equipment , such as expertly designed carpet steam cleaner ... Pro Plus 200S for apartment dwellers and homeowners. The ... in 15 minutes and pressure levels up to 75 ... can be used to clean carpet spots and areas ...
(Date:6/17/2013)... Bust’DD (pronounced ‘busted’), a new company that will provide bras ... busts, will soon launch their crowdfunding campaign on Indiegogo. The ... of ill-fitting bras and want to offer beautiful, quality intimate ... at least $25,000 to create their beta product line with ... scale. , In order to kick off the campaign and ...
(Date:6/17/2013)... June 17, 2013 Today, Zane ... HRAs for small businesses . Zane Benefits, which ... sponsored health benefits, is the leader in ... . , According to Zane Benefits’ website, stand-alone ... or HRAs, offer small businesses an affordable way ...
(Date:6/17/2013)... 2013 Dallas-based physician Dr. Connie Casad ... offer the hybrid concierge model from Concierge Choice Physicians. ... her patients a wider variety of options and to ... emphasis on prevention and wellness had that option. The ... concierge-style of medicine, but doesn't force the physician's longtime ...
Breaking Medicine News(10 mins):Health News:Can new FDA graphic warning labels for tobacco pass a first amendment legal challenge? 2Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 2Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 3Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 2Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 3Health News:Zane Benefits Publishes New Information on Stand-Alone HRAs for Small Businesses 2Health News:Dr. Casad Offers Hybrid Concierge Model from Concierge Choice Physicians 2Health News:Dr. Casad Offers Hybrid Concierge Model from Concierge Choice Physicians 3
... African Chamber of Commerce (USACC) has expressed concern recently following Pope ... outrage among health agencies and others who are on the front ... ... DC (Vocus) April 11, 2009 -- The United States African ...
... say, , , FRIDAY, April 10 (HealthDay News) -- U.S. ... raise the risk of schizophrenia in some people, a ... The study involved a genetic analysis of 24 Canadian ... DNA change that increases gene expression was found in ...
... and mercury exposure , , SATURDAY, April 11 (HealthDay News) -- ... for optimal maternal health and fetal growth and development. That ... how much seafood moms-to-be can safely consume without exposing their ... of ongoing debate. , The U.S. Food and Drug ...
... Center is Now Open , ... (PRWEB) April 11, 2009 -- iCRco ... by the US army in August of 2008. Units from the initial ... on a regular basis throughout 2009. To serve the US military optimally ...
... Dr. Rajesh Khanna discusses success of a new procedure, PRELEX. ... ... In the upcoming May issue of Valley Life (West Valley Magazine), ... his practice and his latest procedure PRELEX. PRELEX treats the condition ...
... April 11 Following is the daily "Profile America" ... http://www.newscom.com/cgi-bin/prnh/20090226/CENSUSLOGO ) SATURDAY, APRIL 11: DONATE LIFEProfile ... month of spring and resurgence. It,s also National ... donation to give a new lease on life to ...
Cached Medicine News:Health News:Pope Benedict Calls for Sex Without Condoms in Africa 2Health News:Gene Variant Tied to Schizophrenia 2Health News:How Much Fish to Eat While Pregnant? 2Health News:How Much Fish to Eat While Pregnant? 3Health News:iCRco Adds New Facility to Serve the United States Military 2Health News:Dr. Khanna Featured on Front Cover of Valley Life Magazine 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: